Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,097,317
+$34,791,037 QoQ
Shares Held
463,163
+395.6% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#25
of 282 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Jun 30, 2026CallValue
$474,555
CallShares
5,100
PutValue
$1,163,125
PutShares
12,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. BNTX ranks #11 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in BNTX
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $474,555 | 5,100 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $43,097,317 | 463,163 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,163,125 | 12,500 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $1,111,000 | 12,500 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $8,306,280 | 93,455 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,173,216 | 13,200 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $666,400 | 7,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $1,713,600 | 18,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $324,822 | 3,412 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $9,260,802 | 101,700 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $3,438,061 | 37,756 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $400,664 | 4,400 | Call | Sole | 2025-05-15 | |
| 2024-09-30 | $641,358 | 5,400 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $73,692,746 | 620,466 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $35,785,401 | 301,300 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $36,637,570 | 455,918 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,536,909 | 190,102 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $37,885,809 | 348,728 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $14,123,200 | 130,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $21,046,350 | 195,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $16,580,638 | 153,624 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $17,054,176 | 113,528 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,057,054 | 7,837 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $741,474 | 4,973 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $18,500,302 | 108,468 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $10,497,830 | 38,455 | Shares | Sole | 2021-12-01 | |
| 2021-09-30 | $17,744,350 | 65,000 | Put | Sole | 2021-12-01 | |
| 2021-06-30 | $2,910,440 | 13,000 | Put | Sole | 2021-08-16 | |
| 2021-03-31 | $18,453,110 | 169,000 | Put | Sole | 2021-05-17 | |
| 2020-12-31 | $8,559,600 | 105,000 | Put | Sole | 2021-02-16 | |
| 2020-09-30 | $3,461,500 | 50,000 | Put | Sole | 2020-11-16 | |
| 2020-09-30 | $12,573,483 | 181,619 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $12,461,400 | 180,000 | Call | Sole | 2020-11-16 | |
| 2020-06-30 | $7,341,400 | 110,000 | Call | Sole | 2020-08-14 | |
| 2020-06-30 | $14,401,490 | 215,785 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||